Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

27.05USD
9:00pm BST
Change (% chg)

$0.65 (+2.46%)
Prev Close
$26.40
Open
$26.33
Day's High
$27.47
Day's Low
$26.14
Volume
88,434
Avg. Vol
175,386
52-wk High
$35.55
52-wk Low
$21.67

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.325
FY 2018 Dec '18 0.00 -0.251
Sep '18 0.00 -0.377
Jun '18 0.00 -1.193
Mar '18 0.00 -0.099
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 11 0.00 0.00 0.00 --
Quarter Ending Dec-19 11 0.00 0.00 0.00 --
Year Ending Dec-19 11 0.00 0.00 0.00 --
Year Ending Dec-20 11 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-19 10 -0.53 -0.40 -0.59 --
Quarter Ending Dec-19 10 -0.63 -0.44 -0.71 --
Year Ending Dec-19 10 -1.95 -1.53 -2.10 --
Year Ending Dec-20 11 -2.37 -1.71 -2.89 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 21.40 19.24
P/E High - Last 5 Yrs. -- 259.58 23.82
P/E Low - Last 5 Yrs. -- 24.11 11.63
Beta -- 1.41 1.43
Price to Sales (TTM) -- 72.96 5.91
Price to Book (MRQ) -- 0.77 2.78
Price to Tangible Book (MRQ) -- 1.12 2.86
Price to Cash Flow (TTM) -- 17.83 22.86
% Owned Institutions -- 0.65 0.64

Dividends

  Company industry sector
Dividend Yield -- 2.53 1.93
Dividend Yield - 5 Year Avg -- 2.43 2.02
Dividend 5 Year Growth Rate -- 10.06 20.70
Payout Ratio(TTM) -- 21.10 18.79

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 233.80 16.36
Sales (TTM) vs TTM 1 Yr. Ago -- 73.49 10.55
Sales - 5 Yr. Growth Rate -- 15.65 13.80
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 40.00 36.69
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.10 10.44
Capital Spending - 5 Yr. Growth Rate -- 21.78 18.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 0.47 0.04
Current Ratio (MRQ) -- 2.12 1.50
LT Debt to Equity (MRQ) -- 834.95 32.09
Total Debt to Equity (MRQ) -- 1,016.37 68.89
Interest Coverage (TTM) -- 21.77 12.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 33.28 3.20
Gross Margin - 5 Yr. Avg. -- 42.17 2.87
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 36.20 48.22
Operating Margin (TTM) -- 26.13 36.93
Operating Margin - 5 Yr. Avg. -- 29.36 40.92
Pre-Tax Margin (TTM) -- 22.86 37.40
Pre-Tax Margin - 5 Yr. Avg. -- 25.63 41.37
Net Profit Margin (TTM) -- 16.92 29.96
Net Profit Margin - 5 Yr. Avg. -- 19.04 32.81
Effective Tax Rate (TTM) -- 25.54 21.01
Effective Tax Rate - 5 Yr. Avg. -- 29.27 20.79

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 142,375,188 52,858,966
Net Income/Employee (TTM) -- 15,544,880 19,013,774
Receivable Turnover (TTM) -- 597.63 12,091.21
Inventory Turnover (TTM) -- 64.27 1.22
Asset Turnover (TTM) -- 0.12 0.02

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 1.02 2.62
Return on Assets - 5 Yr. Avg. -- 1.88 2.81
Return on Investment (TTM) -- 1.71 0.44
Return on Investment - 5 Yr. Avg. -- 2.87 0.44
Return on Equity (TTM) -- 6.73 15.61
Return on Equity - 5 Yr. Avg. -- 12.05 19.79

Performance for Allogene Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 75
13 Week -- -- -- 75
26 Week -- -- -- 70
52 Week -- -- -- 71
YTD -- -- -- 74
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.32%
# of Holders: 138
Total Shares Held: 62,379,522
3 Mo. Net Change: -3,464,685
# New Positions: 10
# Closed Positions: 0
# Increased Positions: 15
# Reduced Positions: 8
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.